Matinas Biopharma Holdings, Inc. (MTNB): Price and Financial Metrics
MTNB Price/Volume Stats
| Current price | $0.62 | 52-week high | $21.50 |
| Prev. close | $0.58 | 52-week low | $0.50 |
| Day low | $0.54 | Volume | 120,900 |
| Day high | $0.67 | Avg. volume | 78,688 |
| 50-day MA | $2.46 | Dividend yield | N/A |
| 200-day MA | $7.56 | Market Cap | 3.13M |
MTNB Stock Price Chart Interactive Chart >
Matinas Biopharma Holdings, Inc. (MTNB) Company Bio
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections.
MTNB Price Returns
| 1-mo | -80.69% |
| 3-mo | -87.97% |
| 6-mo | N/A |
| 1-year | -94.10% |
| 3-year | -98.86% |
| 5-year | -98.90% |
| YTD | -94.26% |
| 2023 | -56.76% |
| 2022 | -50.50% |
| 2021 | -25.74% |
| 2020 | -40.09% |
| 2019 | 281.51% |
Loading social stream, please wait...